Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Machining Center Has Linear Scales and Approx. Five Micron Position Accuracy

June 28, 2010 6:40 am | Datron Dynamics, Inc. | Product Releases | Comments

Datron Dynamics Inc. has announced the release of the M10 Pro, the next generation in their line of German-engineered high speed machining centers that includes significant advancements in their machining technology.

International study identifies 12 new genetic risk factors for type 2 diabetes

June 28, 2010 6:38 am | by EurekAlert | News | Comments

(Helmholtz Zentrum München - German Research Center for Environmental Health) An international consortium including Helmholtz Zentrum Muenchen and the German Diabetes Center, Duesseldorf, has identified 12 new gene variants which impact the individual's risk of developing type 2...

TOPICS:

Partners CIO Glaser heads to Siemens

June 28, 2010 6:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Siemens Healthcare has hired away Partners Healthcare CIO John Glaser to head up its global healthcare IT business. The job change ends Glaser's tenure as CIO at Partners, which had lasted 15 years.

TOPICS:
Advertisement

Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline

June 28, 2010 6:37 am | by Bio-Medicine.Org | News | Comments

MAPLE GROVE, Minn. , June 28 /- Upsher-Smith Laboratories, Inc. today announced an agreement with Ikano Therapeutics, Inc. to obtain exclusive global rights to ITI-111, Ikano's nasal midazolam.  Under terms of the agreement, Upsher-Smith will assume all further development, testing...

TOPICS:

New Data Demonstrates Victoza® (liraglutide rDNA injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at On...

June 28, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. , June 28 /- Poster 16LB -- Late-breaking Novo Nordisk (NVO) extension data presented today at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) showed that once-daily Victoza ® in combination with metformin produced sustained and...

TOPICS:

New Data Shows Investigational Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes

June 28, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. , June 28 /- Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a...

TOPICS:

International child-health experts to converge on London for Excellence in Pediatrics

June 28, 2010 6:34 am | by EurekAlert | News | Comments

(Wiley-Blackwell) Excellence in Pediatrics will provide an up-to-date and authoritative overview of pediatrics and child health through a variety of innovative sessions, designed for general and specialist health professionals. It will focus on four thematic streams: infectious...

TOPICS:

New High-Resolution Computer Tomography Data Demonstrates EVISTA(R)'s Effect on Bone Quality in Osteoporotic Patients

June 28, 2010 1:33 am | by Bio-Medicine.Org | News | Comments

MUNICH , June 28, 2010 /- - 3D Images Provide New Approach to Monitoring Bone Changes Interim data from a prospective Investigator Initiated Trial (IIT) presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow , demonstrates that EVISTA(R) (raloxifene 60mg; once-d...

TOPICS:
Advertisement

Combination MMRV Vaccine Associated with Two-Fold Risk of Febrile Seizures Compared with Separate MMR & Varicella Vaccines

June 27, 2010 10:35 pm | by Bio-Medicine.Org | News | Comments

OAKLAND, Calif. , June 28 /- The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and...

TOPICS:

Global Pharmaceutical R & D Productivity Declining According to Thomson Reuters, CMR International

June 27, 2010 10:35 pm | by Bio-Medicine.Org | News | Comments

PHILADELPHIA and LONDON , June 28 /- The pharmaceutical industry continues to rely heavily on sales from an aging portfolio of drugs, whilst the proportion of total sales from newer drugs has dropped, according to data released today from the 2010 Pharmaceutical R&D Factbook complied...

TOPICS:

Researchers develop accurate way to predict the age when women will hit the menopause

June 27, 2010 8:40 pm | by EurekAlert | News | Comments

(European Society of Human Reproduction and Embryology) Researchers have developed a way of accurately predicting when women will hit the menopause using a simple blood test. The average difference between the predicted age and the actual age that the women in their study reached...

TOPICS:

Healthier cafeteria food, more intense gym classes lower students' diabetes risk

June 27, 2010 8:40 pm | by EurekAlert | News | Comments

(University of California - Irvine) Healthier cafeteria choices, longer and more intense periods of physical activity and robust in-school education programs can lower rates of obesity and other risk factors for type 2 diabetes, according to a national study called HEALTHY.

TOPICS:

Intervention lowered obesity rate in youth at high diabetes risk, HEALTHY study finds

June 27, 2010 8:40 pm | by EurekAlert | News | Comments

(NIH/National Institute of Diabetes and Digestive and Kidney Diseases) An intervention in middle schools lowered the obesity rate in students at highest risk for type 2 diabetes, those who started out overweight or obese in sixth grade, an NIH-funded study has found. However,...

TOPICS:

Building a Substitute Pancreas for Diabetics

June 27, 2010 8:38 pm | by Massachusetts Institute of Technology | News | Comments

A startup hopes implanted insulin-producing cells will free diabetics from insulin injections.

TOPICS:

Statins associated with lower cancer recurrence following prostatectomy

June 27, 2010 8:34 pm | by EurekAlert | News | Comments

(Duke University Medical Center) Men who use statins to lower their cholesterol are 30 percent less likely to see their prostate cancer come back after surgery compared to men who do not use the drugs, according to researchers at Duke University Medical Center. Researchers also...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading